TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20834039

Group type: EXPERIMENTAL
Intervention: Laquinimod 0.3/0.6 mg doses
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Laquinimod 0.6 mg
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo to Laquinimod 0.3/0.6 mg
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Laquinimod 0.6 mg/day
Number of subjects: 257
Study: 18215593

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 15998706

Group type: EXPERIMENTAL
Intervention: Spironolactone (50 mg per day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Triamterene (50 mg per day)
Number of subjects: 38
Study: 12860942

Group type: COMPARATOR
Intervention: Oxaliplatin at 130 mg/m2 every 3 weeks
Number of subjects: 37
Study: 10397122

Group type: EXPERIMENTAL
Intervention: Positive contrast agent (27 patients)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Negative contrast agent (30 patients)
Number of subjects: 57
Study: 8814682

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg
Number of subjects: 378

Group type: COMPARATOR
Intervention: Megestrol acetate
Number of subjects: 378
Study: 1804746

Group type: EXPERIMENTAL
Intervention: Schedule A: amiodarone infusion at a rate of 1.5 mg/kg/h up to two hours after restoration of sinus rhythm or to a maximum dose of 1200 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Schedule B: single amiodarone infusion of 300 mg over 15 minutes, followed by a 300 mg maintenance dose over three hours
Number of subjects: 28
Study: 6300213

Group type: EXPERIMENTAL
Intervention: Antigen
Number of subjects: 27

Group type: COMPARATOR
Intervention: Buffer
Number of subjects: 27
Study: 31858754

Group type: EXPERIMENTAL
Intervention: Anyfusion® method
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 22
Study: 30352746

Group type: COMPARATOR
Intervention: Homeopathic vaccine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Conventional Tdap and MMR vaccines
Number of subjects: 150
Study: 27846256

Group type: EXPERIMENTAL
Intervention: rAd35-EnvA 1010 PU
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: rAd35-EnvA 1011 PU
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: rAd5-EnvA 1010 PU
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: rAd35-EnvA
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: rAd5-EnvA and rAd35-EnvA (heterologous prime-boost)
Number of subjects: 25

Group type: COMPARATOR
Intervention: rAd5-EnvA
Number of subjects: 25
Study: 25010536

Group type: EXPERIMENTAL
Intervention: Coma Recovery Scale-Revised (CRS-R)
Number of subjects: 180
Study: 23216985

Group type: EXPERIMENTAL
Intervention: nimesulide 100mg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: simvastatin 20mg/day
Number of subjects: 150

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 150
Study: 20453154

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill exercise (T-EX) therapy for 3 to 6 months
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill exercise (T-EX) therapy
Number of subjects: 52
Study: 19089281

Group type: EXPERIMENTAL
Intervention: Composite resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poly-acid-modified composite resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional composite resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All materials
Number of subjects: 0
Study: 16203842

Group type: EXPERIMENTAL
Intervention: Culturally appropriate home safety intervention including counseling, assessment of maternal safety practices, and provision of safety items.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group status
Number of subjects: 82
Study: 12851127

Group type: EXPERIMENTAL
Intervention: Vacuum constriction device (VCD) with couples psychotherapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Couples psychotherapy without VCD
Number of subjects: 45
Study: 10680455

Group type: EXPERIMENTAL
Intervention: Squamous cell carcinoma antigen (SCC) in preliminary study
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Squamous cell carcinoma antigen (SCC) in monitoring
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 73
Study: 8947084

Group type: EXPERIMENTAL
Intervention: Motivational approach (nurse-conducted 5 min consultation, brochures, advice)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Motivational approach
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507
Study: 1879086

Group type: EXPERIMENTAL
Intervention: Cicaprost (2.5 micrograms or 5 micrograms t.i.d.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Matching placebo tablets
Number of subjects: 14
Study: 6751339

Group type: EXPERIMENTAL
Intervention: Bromocriptine (30-50 mg daily)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Amitriptyline (120-200 mg daily)
Number of subjects: 83
Study: 31005271

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg + Ezetimibe 10 mg
Number of subjects: 0
Study: 27725655

Group type: EXPERIMENTAL
Intervention: Active rTMS (n=34)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham rTMS (n=39)
Number of subjects: 73
Study: 26839152

Group type: EXPERIMENTAL
Intervention: OFI‐ALA‐PDT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional ALA‐PDT
Number of subjects: 60
Study: 24833598

Group type: EXPERIMENTAL
Intervention: Whey protein (WH)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Casein protein (CAS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Carbohydrate placebo (PLA)
Number of subjects: 44
Study: 22796496

Group type: EXPERIMENTAL
Intervention: Paclitaxel‐eluting balloon (PEB)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 92
Study: 19250283

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 16999931

Group type: EXPERIMENTAL
Intervention: Digital clock with five different interface modes
Number of subjects: 80
Study: 15220226

Group type: EXPERIMENTAL
Intervention: 5 mg/day Alendronate (ALN) for 2 years, followed by 10 mg/day for the remainder of the trial
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 17000586

Group type: EXPERIMENTAL
Intervention: Low-dose hormone therapy (1 mg estradiol plus 0.5 mg norethisterone)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High-dose hormone therapy (2 mg estradiol plus 1 mg norethisterone)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Calcium 1 mg/day (control group)
Number of subjects: 48
Study: 10919731

Group type: EXPERIMENTAL
Intervention: Chewing tobacco
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alcohol drinking
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tobacco chewing and low vegetable intake
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alcohol drinking and low vegetable intake
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alcohol drinking and low fruit intake
Number of subjects: 100
Study: 8857486

Group type: EXPERIMENTAL
Intervention: Z-derived end-diastolic volume
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Z-derived stroke volume
Number of subjects: 115

Group type: COMPARATOR
Intervention: Teichholz' M-mode volume method
Number of subjects: 115
Study: 1517477

Group type: EXPERIMENTAL
Intervention: 0.2% delmopinol hydrochloride
Number of subjects: 6

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine digluconate
Number of subjects: 6
Study: 6147422

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard regimen of intramuscular morphine sulfate
Number of subjects: 13
Study: 30938806

Group type: COMPARATOR
Intervention: Negative control (NC) diet with 1.3 g nPP/kg starter diet or 1.1 g nPP/kg grower diet
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: NC diet with increasing levels of residual phytase C (500, 1,000, 2,000, 3,000, and 4,000 units/kg feed)
Number of subjects: 560

Group type: COMPARATOR
Intervention: NC diet
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: NC diet with increasing residual superdoses of phytase C
Number of subjects: 560

Group type: COMPARATOR
Intervention: NC treatment
Number of subjects: 560
Study: 29954702

Group type: EXPERIMENTAL
Intervention: Active rTMS treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS treatment
Number of subjects: 0
Study: 27756288

Group type: EXPERIMENTAL
Intervention: Mobile application for learning palpation and ultrasound skills
Number of subjects: 49

Group type: COMPARATOR
Intervention: Traditional learning materials
Number of subjects: 49
Study: 24122242

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (colon cancer subgroup)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open surgery (colon cancer subgroup)
Number of subjects: 100
Study: 22317952

Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m(2) every 3 weeks (C)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m(2) IV on day 1 and gemcitabine 1250 mg/m(2) on days 1 and 8 every 3 weeks (CG)
Number of subjects: 52
Study: 19011374

Group type: EXPERIMENTAL
Intervention: Tdap-IPV after Td-IPV
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo followed by Tdap-IPV
Number of subjects: 500
Study: 17199721

Group type: EXPERIMENTAL
Intervention: LC n‐3 PUFA supplementation for 12 weeks
Number of subjects: 30
Study: 16333765

Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment in subclinical hypothyroidism
Number of subjects: 161

Group type: COMPARATOR
Intervention: Hyperthyroid patients
Number of subjects: 161

Group type: COMPARATOR
Intervention: Overt hypothyroidism
Number of subjects: 161

Group type: COMPARATOR
Intervention: Subclinical and overt hypothyroid subjects
Number of subjects: 161
Study: 11997413

Group type: EXPERIMENTAL
Intervention: Nominal output pacing treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham pacing treatment
Number of subjects: 15
Study: 10531890

Group type: EXPERIMENTAL
Intervention: audiotaped lullabies during immunizations
Number of subjects: 99

Group type: COMPARATOR
Intervention: no intervention (control group)
Number of subjects: 99
Study: 7632811

Group type: EXPERIMENTAL
Intervention: rHu-EPO at an initial dosage of 150 units/kg body weight three times a week, increased to 300 units/kg from the sixth week to the end of the 24-week study
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: rHu-EPO
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: rHu-EPO combined with alpha-interferon (alpha-IFN)
Number of subjects: 54

Group type: COMPARATOR
Intervention: rHu-EPO-untreated patients undergoing alpha-IFN + VMCP combined therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: rHu-EPO-treated patients not receiving alpha-IFN
Number of subjects: 54
Study: 31928890

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol (IPA) for 5, 10, or 15 seconds
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate (CHG) in 70% IPA for 5, 10, or 15 seconds
Number of subjects: 300
Study: 30564936

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (unsupervised walking, stationary bike, swimming, resistance exercise DVDs, pedometer, exercise log)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 71
Study: 28687322

Group type: EXPERIMENTAL
Intervention: Chemically modified tetracycline (CMT, incyclinide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo Control
Number of subjects: 0
Study: 25518813

Group type: EXPERIMENTAL
Intervention: Comprehensive periodontal therapy during pregnancy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Comprehensive periodontal therapy after delivery
Number of subjects: 109
Study: 23223803

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment for 2 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy comparison subjects (control group)
Number of subjects: 21
Study: 21490090

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study: 19734396

Group type: EXPERIMENTAL
Intervention: Cinnamon capsules, 1g daily for 90 days
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 109
Study: 16955282

Group type: EXPERIMENTAL
Intervention: Escitalopram 5 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 15471755

Group type: EXPERIMENTAL
Intervention: Internet questionnaires
Number of subjects: 397

Group type: COMPARATOR
Intervention: Mailed questionnaires
Number of subjects: 397
Study: 11239185

Group type: EXPERIMENTAL
Intervention: Neuroprotective drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimum clinically important differences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidemiological and cost-effectiveness models
Number of subjects: 0
Study: 9239588

Group type: EXPERIMENTAL
Intervention: Convection cooling (CC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional conduction cooling (TC)
Number of subjects: 20
Study: 8255984

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (8g/70kg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2442957

Group type: EXPERIMENTAL
Intervention: Phenylalanine restricted diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Free diet with tyrosine (160 mg/kg/24 h)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Free diet supplemented with tyrosine
Number of subjects: 9
Study: 30788529

Group type: EXPERIMENTAL
Intervention: Baclofen 30 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Baclofen 75 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29735006

Group type: EXPERIMENTAL
Intervention: HLA matching
Number of subjects: 721

Group type: COMPARATOR
Intervention: Random graft assignment (Control)
Number of subjects: 721
Study: 27991018

Group type: EXPERIMENTAL
Intervention: 3-dimensional mesh for prevention
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no mesh) for prevention
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 3-dimensional mesh for repair
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no mesh) for repair
Number of subjects: 116
Study: 24450968

Group type: EXPERIMENTAL
Intervention: Previous diagnosis of depression
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: Poor vision (as determined from a Visual Function Questionnaire)
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: Poor vision (in subgroup without previous diagnosis of depression)
Number of subjects: 1085
Study: 22648715

Group type: EXPERIMENTAL
Intervention: High dietary polyamine intake (above the median amount)
Number of subjects: 1164
Study: 20146136

Group type: EXPERIMENTAL
Intervention: Dual-task training (experimental treatment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-specific cognitive training (control)
Number of subjects: 12
Study: 18357573

Group type: EXPERIMENTAL
Intervention: Parents of girls with adolescent onset of bipolar disorder
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Parents of boys with childhood onset of bipolar disorder
Number of subjects: 44
Study: 15938028

Group type: EXPERIMENTAL
Intervention: Patient Participation (PP) program
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard Consultation (SC)
Number of subjects: 165
Study: 12570122

Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin (400 mg o.d.)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Standard oral therapy (amoxicillin 1 g t.i.d. or clarithromycin 500 mg b.i.d. alone or in combination)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Standard oral therapy (amoxicillin or clarithromycin)
Number of subjects: 564
Study: 10475293

Group type: EXPERIMENTAL
Intervention: epinephrine 0.5 microg/kg group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: epinephrine 0.25 microg/kg group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: epinephrine 0.125 microg/kg group
Number of subjects: 80

Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 80
Study: 8946270

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice a day for 12 months
Number of subjects: 0
Study: 1751442

Group type: EXPERIMENTAL
Intervention: Continuous wave Doppler studies of umbilical and uteroplacental arterial circulations
Number of subjects: 505
Study: 6126961

Group type: COMPARATOR
Intervention: celiprolol (100 mg t.i.d.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: propranolol (40 mg t.i.d.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: celiprolol
Number of subjects: 21

Group type: COMPARATOR
Intervention: propranolol
Number of subjects: 21

Group type: COMPARATOR
Intervention: celiprolol and propranolol
Number of subjects: 21
Study: 31103444

Group type: EXPERIMENTAL
Intervention: Implementation intentions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restrictions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29710119

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard blood pressure lowering
Number of subjects: 167
Study: 26881251

Group type: EXPERIMENTAL
Intervention: Ranirestat 20 mg once daily
Number of subjects: 0
Study: 24708851

Group type: EXPERIMENTAL
Intervention: Complete Decongestive Therapy including manual drainage
Number of subjects: 160

Group type: COMPARATOR
Intervention: Complete Decongestive Therapy without manual lymphatic drainage
Number of subjects: 160
Study: 22769857

Group type: EXPERIMENTAL
Intervention: Ultracet (37.5 mg tramadol/325 mg APAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Depain‐X (65 mg propoxyphene/650 mg APAP)
Number of subjects: 60
Study: 20144496

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (1 mL) plus Ringer lactate during arthroscopy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ringer lactate during arthroscopy
Number of subjects: 40
Study: 17184378

Group type: EXPERIMENTAL
Intervention: Broad-based search strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free text search strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thesaurus search strategy
Number of subjects: 0
Study: 15850471

Group type: EXPERIMENTAL
Intervention: 1.6 mg Talpha1 monotherapy
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: 0.8 mg Talpha1 monotherapy
Number of subjects: 316
Study: 12399722

Group type: EXPERIMENTAL
Intervention: Phenol red thread test (PRT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Schirmer I test
Number of subjects: 54
Study: 10365315

Group type: EXPERIMENTAL
Intervention: Yoga practices
Number of subjects: 50
Study: 7675981

Group type: COMPARATOR
Intervention: Inositol as sole therapy for depression
Number of subjects: 49

Group type: COMPARATOR
Intervention: Inositol for panic disorder
Number of subjects: 49
Study: 2167789

Group type: EXPERIMENTAL
Intervention: Water immersion at 20 degrees C for 2 min
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Water immersion at 0-4 degrees C for 2 min
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mental arithmetic for two periods of 2 min
Number of subjects: 11
Study: 7148050

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.0 mg/kg body weight)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Mexiletine (1.5 mg/kg body weight)
Number of subjects: 9
Study: 29857075

Group type: EXPERIMENTAL
Intervention: Tooth Mousse (CPP‐ACP group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Deionized water (control group)
Number of subjects: 12
Study: 27914519

Group type: EXPERIMENTAL
Intervention: Study formula with DHASCO®-B (17mg DHA/100kcal)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Study formula with DHASCO®-B
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control formula (DHASCO®)
Number of subjects: 267
Study: 25659477

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 23686414

Group type: EXPERIMENTAL
Intervention: MTX monotherapy
Number of subjects: 755

Group type: COMPARATOR
Intervention: Immediate combination therapy
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: MTX monotherapy (step-up at 24 weeks)
Number of subjects: 755
Study: 20158090

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 mg to 45 mg)
Number of subjects: 5238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238

Group type: COMPARATOR
Intervention: Glimepiride (1 to 4 mg)
Number of subjects: 5238
Study: 18258791

Group type: EXPERIMENTAL
Intervention: Topical esophageal lidocaine (15 ml)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Prior mucosal acid exposure
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Balloon distension
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Baclofen (40 mg orally)
Number of subjects: 55
Study: 16636123

Group type: EXPERIMENTAL
Intervention: 0.5 mg potassium perchlorate daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 3.0 mg potassium perchlorate daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 14679692

Group type: EXPERIMENTAL
Intervention: New fistula on the same vascular level (Group I, N=56)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Fistula at a higher level (Group II, N=31)
Number of subjects: 274